Development of Recombinant Antibody by Yeast Surface Display Technology
Recombinant antibodies have emerged as powerful tools in various fields, including therapeutics, diagnostics, and research applications. The selection of high-affinity antibodies with desired specificity is a crucial step in the development of recombinant antibody-based products. In recent years, ye...
Saved in:
Main Authors: | Mujahed I. Mustafa (Author), Awad A. Alzebair (Author), Ahmed Mohammed (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing a plasmid for surface display containing the recombinant E6 protein of human papilloma virus type 18 for expression in yeast Yarrowia lipolytica
by: Mohaddeseh Koohichapan, et al.
Published: (2022) -
Reduction of therapeutic antibody self-association using yeast-display selections and machine learning
by: Emily K. Makowski, et al.
Published: (2022) -
Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting
by: Wei Sun, et al.
Published: (2019) -
Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits
by: Yuxin Hao, et al.
Published: (2024) -
A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine
by: Ziyu Wen, et al.
Published: (2023)